The Leadership Team at Resverlogix steers the company's strategic direction, overseeing operations and ensuring alignment with its mission to develop therapeutics for cardiovascular diseases and Alzheimer’s disease. This team, composed of the President & CEO, Chief Scientific Officer, CFO, SVP of Clinical Development, and VP of Intellectual Property, collaborates to manage financial performance, guide clinical development, protect intellectual property, and advance scientific research.
View all